Nomogram for predicting pathological complete response to neoadjuvant chemotherapy in patients with advanced gastric cancer

BACKGROUND: Survival benefit of neoadjuvant chemotherapy (NAC) for advanced gastric cancer (AGC) is a debatable issue. Studies have shown that the survival benefit of NAC is dependent on the pathological response to chemotherapy drugs. For those who achieve pathological complete response (pCR), NAC...

Descripción completa

Guardado en:
Detalles Bibliográficos
Publicado en:World J Gastroenterol
Autores principales: Chen, Yong-He, Xiao, Jian, Chen, Xi-Jie, Wang, Hua-She, Liu, Dan, Xiang, Jun, Peng, Jun-Sheng
Formato: Artigo
Lenguaje:Inglês
Publicado: Baishideng Publishing Group Inc 2020
Materias:
Observational Study
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC7243641/
https://ncbi.nlm.nih.gov/pubmed/32476803
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3748/wjg.v26.i19.2427
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!

Ejemplares similares